Financial Ratios

EMMESSAR BIOTECH & NUTRITION LTD.

NSE : NABSE : 524768ISIN CODE : INE634B01016Industry : Pharmaceuticals & DrugsHouse : Private
BSE29.720.46 (+1.57 %)
PREV CLOSE ( ) 29.26
OPEN PRICE ( ) 29.80
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 9023
TODAY'S LOW / HIGH ( )28.51 30.70
52 WK LOW / HIGH ( ) 21.147.69
NSE
This Company is not listed in NSE
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)1.010.952.901.511.07
   CEPS(Rs)1.201.143.021.621.22
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)13.3412.3511.418.537.02
   Tax Rate(%)47.9048.9635.70-2.18-81.39
Margin Ratios
   Core EBITDA Margin(%)-67.59-244.9712.13-11.88-101.55
   EBIT Margin(%)95.00255.5532.2721.7946.92
   Pre Tax Margin(%)94.87255.2832.2521.7246.67
   PAT Margin (%)49.43130.2820.7422.1984.66
   Cash Profit Margin (%)58.61155.5821.5623.9097.15
Performance Ratios
   ROA(%)6.426.3022.4714.9312.75
   ROE(%)7.858.0129.1019.4016.42
   ROCE(%)14.9915.7145.2918.879.00
   Asset Turnover(x)0.130.051.080.670.15
   Sales/Fixed Asset(x)0.500.162.691.300.23
   Working Capital/Sales(x)0.180.081.751.570.42
Efficiency Ratios
   Fixed Capital/Sales(x)1.996.330.370.774.38
   Receivable days4.241361.8671.443.4820.78
   Inventory Days36.6067.7531.75100.88236.30
   Payable days752.5067.17163.34856.62
Valuation Parameters
   PER(x)24.5928.905.077.5616.73
   PCE(x)20.7424.204.877.0214.58
   Price/Book(x)1.862.231.291.342.54
   Yield(%)0.000.000.000.000.00
   EV/Net Sales(x)7.1425.090.701.1213.15
   EV/Core EBITDA(x)6.868.932.113.5912.53
   EV/EBIT(x)7.529.822.165.1528.02
   EV/CE(x)0.901.210.650.701.77
   M Cap / Sales12.1637.651.051.6814.17
Growth Ratio
   Net Sales Growth(%)179.31-94.78105.86439.46-49.76
   Core EBITDA Growth(%)3.61-55.71117.9260.71-22.16
   EBIT Growth(%)3.83-58.67204.85150.58-63.00
   PAT Growth(%)5.97-67.2192.3541.42-41.66
   EPS Growth(%)5.98-67.2192.3541.43-41.66
Financial Stability Ratios
   Total Debt/Equity(x)0.010.000.000.000.02
   Current Ratio(x)10.705.583.452.652.27
   Quick Ratio(x)10.465.513.411.771.66
   Interest Cover(x)744.77932.501466.98305.67192.52
   Total Debt/Mcap(x)0.010.000.000.000.01

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.